Vertex Pharmaceuticals Incorporated


Warning: file_get_contents(http://finance.google.com/finance/info?q=VRTX): failed to open stream: HTTP request failed! HTTP/1.0 404 Not Found in /home3/mnadeemm/public_html/smartstocknews.com/ticker.php on line 66

(%) Date:

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Inc (VRTX): Orkambi Beats Estimates; Focus Is On Triple Combinations Now

Maxim Group states that Vertex is poised to unlock up to 90% of the CF (cystic fibrosis) market, which reflects a larger heterozygote market and the best case

Here's Why Leerink Wants Gilead Sciences, Inc. (GILD) to Buy Vertex Pharmaceuticals Incorporated (VRTX)

Potential acquisition of Vertex could be meaningfully accretive for Gilead Sciences, according to a Leerink analyst

Oppenheimer Upgrades Vertex Pharmaceuticals Incorporated (VRTX) to Outperform Rating

Vertex impending Phase 1 and 2 triplet data are likely to be successful, according to Oppenheimer analyst

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Kalydeco Approved In CFTR Residual Function

Given the time for payer negotiation on access, Bank of America Merrill Lynch didn’t believe that Kalydeco sales will meaningfully pick up till end of 2Q17